Member Info for Vertizea-Sun

It's worth between 1 billion and who knows?

Thevid.....thanks

At least ten years for a new treatment to proceed from the drawing board to a paying patient. We are just in year 8.

"Is it any different on Nasdaq?"

Quite and none when the share price rockets.

I feel for you. Such a hard life.

Correct BV

Avacta is seeking an investing partner:

So what has Simon Bennett been doing for 14+ months?

"that wonderful interview,"

"AVA6000 is a nuclear bomb on a rocket"

Perhaps not on Monday but likely before the end of next week. Phase 1B trial information will not be broadcast but it will be known and especially on a two week cycle. So anyone on an NDA will weighing up options. A different world by the end of this month? Perhaps.

OK Cj......thanks for the info.

Me too NR11....something doesn't stack up. How are 18.6M shares traded(nearly 5%) without it massively affecting the market price?

"900k is pretty immaterial when you look at their cash burn, but you know that .. right?"

Is LlamaFarmer the new hide-behind for Thornogson/eggy/NDN?

From today's RNS:

" with Tempus AI have demonstrated the broad addressable patient populations that could be targeted with pre|CISION®-enabled medicines."

Presumably cancer only. Is FAP produced by other maladies? Just asking....I've no idea what Avacta means with that sentence. Although I'll repeat myself.....this is spectacular science and we were reminded of that by Janet Munro, a Novartis senior manager.

"Has P1b dosing started yet?"

So what happened to the cancer patients screened in December?

Just left to die?

Imbecile.

"SB works for himself"....slip of the tongue.

Avacta's science is looking spectacular but SB's 14+ months in the job.....who knows?

So why did you waste time in your life answering?

It's Minimouse

Why? What are you expecting?

An answer to Shaun Chilton's " judge us in six months" would be nice. Running three months late.

COLDWATER doesn't know the science so I'll tell him:

1: pre|CISION® as transport. Identifying and targeting cancer tumours via FAP.

2:Warheads. AVA6000 is the first of dozens of potential cancer killers.AVA6103.

3: Affimers as in AffyXell or separately as in AVA7000.

There are three sciences. What price do you put on them.....individually?

Wrong.....you're comparing AIM with NASDAQ.